Page last updated: 2024-11-08

chloramphenicol and Protein-Losing Enteropathies

chloramphenicol has been researched along with Protein-Losing Enteropathies in 2 studies

Amphenicol: Chloramphenicol and its derivatives.

Protein-Losing Enteropathies: Pathological conditions in the INTESTINES that are characterized by the gastrointestinal loss of serum proteins, including SERUM ALBUMIN; IMMUNOGLOBULINS; and at times LYMPHOCYTES. Severe condition can result in HYPOGAMMAGLOBULINEMIA or LYMPHOPENIA. Protein-losing enteropathies are associated with a number of diseases including INTESTINAL LYMPHANGIECTASIS; WHIPPLE'S DISEASE; and NEOPLASMS of the SMALL INTESTINE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GREEN, D1
GEISLER, PH1
ERSLEV, AJ1
Nygaard, K1
Rootwelt, K1

Other Studies

2 other studies available for chloramphenicol and Protein-Losing Enteropathies

ArticleYear
PROTEIN-LOSING ENTEROPATHY COMPLICATING PROLONGED BLEEDING IN HEMOPHILIA.
    Annals of internal medicine, 1964, Volume: 61

    Topics: Aminocaproates; Aminocaproic Acid; Blood Transfusion; Chloramphenicol; Dietary Proteins; Drug Therap

1964
Intestinal protein loss in rats with blind segments on the small bowel.
    Gastroenterology, 1968, Volume: 54, Issue:1

    Topics: Animals; Blood Proteins; Chloramphenicol; Chromium Isotopes; Feces; Ileum; Injections, Intravenous;

1968